Music to your ears. Music to my ears. π΅π΅πΆπΆ
Saregama Q3 result key takeaways: 1. Carvaan sales have picked up to 1.41 cr. But no new capital allocation here. QIP money deployed into music only.
In b/w lines:
No marketing spends on Carvaan.
Still multi quarter high sales volume. All the 700cr raised in QIP will only be deployed into music streaming & artiste management.
Wait what?
Look at the the right side of this pic. This is 1st time saregama has talked about entering artiste management space. They want to find & nurture young talent, give them saregama songs & then get a share of their earnings when they perform in real life. Interesting.
2. 25-30% growth guidance intact.
In b/w lines: As per my calculations the quarter on quarter growth in music streaming has been flat in last 3 years. Management did not confirm or deny the stats I presented.
They did say that they expect to grow 25-30% including inorganic (some of the 700cr QIP can be used to do inorganic acquisition). Any move to paid subscription will be additional growth.
3. Paid subscription is a large opportunity.
In b/w lines: When asked how much of their revenue comes from subscription & how much from ad they mentioned that almost none of it comes from paid subscription. World wide there are 50 million paid subs.
This shows the size of opportunity.
Example given was that if subscription fees was 100 rupees. Saregama's share would be 50 rupees. If one listens to 100 songs a month this would be a 5x upside from the 10 paisa they get currently.
@ishmohit1 1.41 lakh (number of units sold). Each unit costs 3000 rupees approx.
β’ β’ β’
Missing some Tweet in this thread? You can try to
force a refresh
With investors like @LuckyInvest_AK ashish Kacholia sir investing in it, let us look at one of the largest listed e-pharmacies & why I invested in it 8 months ago.
Get ready for a long π§΅. Focus on process.
Please retweet if you find it useful.
A π§΅π§΅π§΅ on SastaSundar ‡οΈ
Outline:
0. Disclaimers 1. Industry Structure & Tailwinds 2. Business Model 3. Growth 4. Profitability 5. Equity Dilution & Fund raising 6. Digital Scuttlebutt 7. Valuations 8. Anti-thesis
0. Disclaimer
Before I start, some disclaimers. My sole reason to share these threads is to share with everyone how I do my research. It is to demonstrate to the retail investor the various ways in which they can have an edge over institutions.
The market expectations were tall. it was at TTM 37 p/e before results. The results are sort of a mixed bag.
1. The revenue growth was ONLY 4% QoQ. That's low given that even larger ones like Infy are growing at 7% QoQ.
In b/w lines: Management mentions that main reason is seasonality. Furlows in Q3 (lot of client development also stops in Q3). Management also mentions that 9M growth is 29% so longer term growth is strong.
My key takeaways: 1. Margin compression in this quarter was a perfect storm.
In b/w the lines: transportation costs went up 2.5% of sales, power costs went up 2% of sales. SDA sales were muted due to semicon shortage.
Despite all of this the operating margin was 23%. Towards lower end of their 23-27% guidance. Semicon shortage expected to ease from may. So sda sales should pick up in Q1fy23. q4 will be muted as well. Gross margins have expanded to 57% from 55% last quarter.
2. Super capacitor Electrolyte salt sales are now 2% of the product mix.
In b/w lines: The conservative guidance is of 5-7% of sales mix 4 years from now. The upside is absolutely huge though. These super capacitors are needed to store solar & wind energy. The upside is massive
Angel one π concall was today. Some key takeaways from Q3Fy22 results:
π§΅π§΅
1. Conventional wisdom goes that broking industry volumes drop off the cliff during bear markets. Angel data reveals that while volumes do decline, this is generally a temporary phenomenon.
This is NOT to say that broking is not cyclical (it is), but the cyclicality might not be as bad as we think it is. Do note that this data includes cash segment volumes from which brokers dont earn anything so take it with a pinch of salt.
Nope, its pitti. π€£π€£ And it is still undervalued imo.
A thread to understand whether pitti deserves our pity or our interest.
Plz retweet if you find it useful. ππ
π§΅π§΅π§΅ππ
Let's dive right into the belly of the beast.
We cover the analysis in 7 sections: 1. Products 2. Industry Analysis 3. Durable Competitive Advantages 4. Growth Triggers 5. Profitability Triggers 6. Valuation 7. Anti thesis 8. What am I doing?
1. Products
Before we understand pittiβs products let us understand the user facing product they go into. Do you know how Electricity is generated at a Hydro power project? Its a turbine.